Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ME1111

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Abstract This study determined ME1111 onychopharmacokinetics and possible topical antifungals’ clinical efficacy in human great… Expand
2017
2017
ABSTRACT ME1111 is a novel antifungal agent currently under clinical development as a topical onychomycosis treatment. A major… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
2016
2016
ABSTRACT The treatment of dermatophytoses, including onychomycosis, has come a long way over the past few decades with the… Expand
  • figure 1
  • table 1
2016
2016
ABSTRACT The effects of ME1111, a novel antifungal agent, on the hyphal morphology and ultrastructure of Trichophyton… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2015
2015
ABSTRACT Despite the existing treatment options for onychomycosis, there remains a strong demand for potent topical medications… Expand
  • table 2
  • table 3
  • table 5
  • figure 2
2015
2015
ABSTRACT Fungal nail infection (onychomycosis) is a prevalent disease in many areas of the world, with a high incidence… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
2015
2015
ABSTRACT The treatment of onychomycosis has improved considerably over the past several decades following the introduction of the… Expand
  • figure 1
  • table 1
  • table 3
  • table 2
  • table 4
2015
2015
ABSTRACT ME1111 is a novel small molecule antifungal agent under development for the topical treatment of onychomycosis… Expand
  • table 1
  • table 2